European Headache Alliance

Monthly Archives: February 2018

PRAC recommends new measures to avoid valproate exposure in pregnancy

The European Medicines Agency’s experts in medicines safety, the Pharmacovigilance Risk Assessment Committee (PRAC) are recommending new measures to avoid exposure of babies to valproate medicines in the womb. Babies exposed are at risk of malformations and developmental problems. The PRAC examined the available evidence and consulted widely with healthcare professionals and with patients, including women…
Read More

Exploratory Research into effect of Migraines in the workplace

This research develops on existing information, providing a deeper and wider spectrum of understanding into the effect of migraines. Reasons why employees choose to be present or absent, how triggers and symptoms can be managed, perceived human capital value, and possible spill overs from the workplace. Throughout, there is a comparison between different types of…
Read More